SPL 2.22% 9.2¢ starpharma holdings limited

Another ADC Buyout - Just not SPL, page-23

  1. 3,359 Posts.
    lightbulb Created with Sketch. 806
    I’d say that Gilead lost Starpharma’s phone number a long time ago. They just stumped up US$4.3B to expand their portfolio. (Not in ADCs)

    Was it just a message that Starpharma left on an answering machine? “Oh hey it’s Starpharma here, we’ve developed DEP-Remdesivir. Please call us back to discuss.”

    Still waiting…

    https://investors.gilead.com/news/news-details/2024/Gilead-Sciences-Expands-Liver-Portfolio-With-Acquisition-of-CymaBay-Therapeutics/default.aspx
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.2¢
Change
0.002(2.22%)
Mkt cap ! $37.93M
Open High Low Value Volume
9.2¢ 9.3¢ 9.2¢ $3.349K 36.18K

Buyers (Bids)

No. Vol. Price($)
2 113072 9.2¢
 

Sellers (Offers)

Price($) Vol. No.
9.3¢ 108436 2
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.